Francois Brisebois
Stock Analyst at Oppenheimer
(0)
# 4415
Out of 5,291 analysts
99
Total ratings
29.55%
Success rate
-13.72%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Sensei Biotherapeuti... | Maintains: Outperform | 4 4 | 0.52 | 669.23% | 2 | Mar 28, 2025 | |
Abeona Therapeutics | Initiates Coverage On: Outperform | 16 | 4.97 | 221.93% | 1 | Mar 5, 2025 | |
Ovid Therapeutics | Upgrades: Outperform | 4 | 0.35 | 1042.86% | 1 | Jan 29, 2025 | |
Tarsus Pharmaceutica... | Maintains: Outperform | 65 72 | 51.78 | 39.05% | 7 | Jan 22, 2025 | |
Mind Medicine | Reiterates: Outperform | 20 20 | 6.21 | 222.06% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 28 | 9.56 | 192.89% | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 29 30 | 8.03 | 273.6% | 8 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 143 163 | 38.31 | 325.48% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 56 59 | 33.19 | 77.76% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 55 55 | 11.46 | 379.93% | 5 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 15 15 | 6.06 | 147.52% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 6 6 | 3.83 | 56.66% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 11 11 | 2.77 | 297.11% | 6 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 14 14 | 14.57 | -3.91% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 15 | 2.91 | 415.46% | 4 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 4.63 | 439.96% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 65 | 24.3 | 167.49% | 5 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 10 10 | 6.7 | 49.25% | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 5 | 0.8 | 525% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 152 | 6.72 | 2161.9% | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 63 36 | 15.98 | 125.28% | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 4 | 2.12 | 88.68% | 3 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 60 | 0.37 | 16116.22% | 3 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 7200 5400 | 2.92 | 184831.51% | 2 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 100 | n/a | n/a | 1 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | 3.01 | 182.39% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 11 | 3.55 | 209.86% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 23 | n/a | n/a | 2 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 18 | 1.5 | 1100% | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | n/a | n/a | 1 | Apr 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 2.94 | 1600.68% | 1 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 19 | n/a | n/a | 1 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | n/a | n/a | 1 | Mar 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 3240 | 1.59 | 203673.58% | 1 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 99 130 | n/a | n/a | 3 | Jan 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Nov 8, 2017 |